171 related articles for article (PubMed ID: 38352864)
1. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer.
Zhang G; Shu Z; Yu J; Li J; Yi P; Wu B; Deng D; Yan S; Li Y; Ren D; Hou Y; Lan C
Front Immunol; 2024; 15():1341209. PubMed ID: 38352864
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection.
Delayre T; Guilbaud T; Resseguier N; Mamessier E; Rubis M; Moutardier V; Fara R; Berdah SV; Garcia S; Birnbaum DJ
Br J Surg; 2020 May; 107(6):720-733. PubMed ID: 31960955
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma.
Kiryu S; Ito Z; Suka M; Bito T; Kan S; Uchiyama K; Saruta M; Hata T; Takano Y; Fujioka S; Misawa T; Yamauchi T; Yanagisawa H; Sato N; Ohkusa T; Sugiyama H; Koido S
BMC Cancer; 2021 Nov; 21(1):1197. PubMed ID: 34758773
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
5. Role of ANO1 in tumors and tumor immunity.
Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ANO1 expression in cancers.
Zhang C; Li H; Gao J; Cui X; Yang S; Liu Z
Medicine (Baltimore); 2021 Jan; 100(4):e24525. PubMed ID: 33530281
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Associated Fibroblasts Affect Intratumoral CD8
Kato T; Noma K; Ohara T; Kashima H; Katsura Y; Sato H; Komoto S; Katsube R; Ninomiya T; Tazawa H; Shirakawa Y; Fujiwara T
Clin Cancer Res; 2018 Oct; 24(19):4820-4833. PubMed ID: 29921731
[No Abstract] [Full Text] [Related]
9. Implication of IL6-positive Cancer-associated Fibroblasts in Merkel Cell Carcinoma Pathogenesis: A Possible Modulator of Immune Microenvironment.
Zheng Z; Yoo DS; Li S; Pei M; Lee SG; Kim JY; Chung KY; Roh MR
Anticancer Res; 2022 Sep; 42(9):4359-4369. PubMed ID: 36039447
[TBL] [Abstract][Full Text] [Related]
10. High level of ANO1 promotes pancreatic cancer growth in concert with oncogenic KRAS.
Zhang L; Wang H; Guo J; Xu H; Qian Y; Sun M
Mol Biol Rep; 2023 Apr; 50(4):3297-3307. PubMed ID: 36715788
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells as a prognostic and predictive marker in gastrointestinal stromal tumors: a prospective study.
Li Q; Zhi X; Zhou J; Tao R; Zhang J; Chen P; Røe OD; Sun L; Ma L
Oncotarget; 2016 Jun; 7(24):36645-36654. PubMed ID: 27153560
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
13. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
[TBL] [Abstract][Full Text] [Related]
14. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C
Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival.
Zhao J; Soto LMS; Wang H; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Wolff RA; Huang Y; Wistuba II; Maitra A; Wang H
Pancreatology; 2021 Aug; 21(5):942-949. PubMed ID: 33832821
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
Front Immunol; 2021; 12():705378. PubMed ID: 34526987
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.
Nallasamy P; Nimmakayala RK; Karmakar S; Leon F; Seshacharyulu P; Lakshmanan I; Rachagani S; Mallya K; Zhang C; Ly QP; Myers MS; Josh L; Grabow CE; Gautam SK; Kumar S; Lele SM; Jain M; Batra SK; Ponnusamy MP
Gastroenterology; 2021 Dec; 161(6):1998-2013.e7. PubMed ID: 34418441
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
[TBL] [Abstract][Full Text] [Related]
19. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
Suzuki J; Aokage K; Neri S; Sakai T; Hashimoto H; Su Y; Yamazaki S; Nakamura H; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Ishii G
Lung Cancer; 2021 Mar; 153():1-10. PubMed ID: 33429158
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
Jiang Y; Cai Y; Shao W; Li F; Guan Z; Zhou Y; Tang C; Feng S
Oncol Rep; 2019 Apr; 41(4):2361-2370. PubMed ID: 30816505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
